TAK-701, a humanized monoclonal antibody to hepatocyte growth factor, reverses gefitinib resistance induced by tumor-derived HGF in non-small cell lung cancer with an EGFR mutation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples